Cardiology Update
SEPTEMBER 24, 2024
Dr. Chadi Alraies discusses some of the important trials presented at the European Society of Cardiology 2024 congress. Read more about the important ESC 2024 highlights. For more cardiology research news join our newsletter or follow us on Twitter , Facebook , LinkedIn or Instagram. The post ESC 2024 Highlights appeared first on Cardiology Update.
Nature Reviews - Cardiology
SEPTEMBER 24, 2024
Nature Reviews Cardiology, Published online: 25 September 2024; doi:10.1038/s41569-024-01068-0 In this Review, Münzel and colleagues describe the adverse effects of soil and water pollution, including heavy metal, pesticide, and microplastic and nanoplastic pollution, on cardiovascular health and provide an overview of the eco-disruptive causes of this pollution.
HCPLive
SEPTEMBER 24, 2024
The FDA has set a PDUFA target action date of May 22, 2025, for roflumilast foam 0.3% for individuals aged ≥12 with scalp and body psoriasis.
Medical Xpress - Cardiology
SEPTEMBER 24, 2024
Women in the UK, and elsewhere, are still missing out on vital treatment for their No 1 killer—cardiovascular disease—despite significant progress in the medical management of heart disease and stroke, concludes a consensus statement published online in the journal Heart.
Med Page Today
SEPTEMBER 24, 2024
(MedPage Today) -- Noninvasive, low‐level tragus stimulation modestly reduced blood pressure (BP) in relatively healthy people with grade 1 hypertension. (Journal of the American Heart Association) The House passed the HEARTS Act, which.
Medical Xpress - Cardiology
SEPTEMBER 24, 2024
A team at the Hübner and Diecke Labs at the Max Delbrück Center has shown how human and non-human primate hearts differ genetically. The study, published in Nature Cardiovascular Research, reveals evolutionary adaptations in human hearts and provides new insights into cardiac disease.
HCPLive
SEPTEMBER 24, 2024
Heplisav-B provided a greater vaccine completion rate and higher HBV seroprotection than the conventional 3-dose Recombivax HB in thoracic organ transplant candidates.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Nature Reviews - Cardiology
SEPTEMBER 24, 2024
Nature Reviews Cardiology, Published online: 25 September 2024; doi:10.1038/s41569-024-01091-1 The burden of atrial fibrillation (AF) is increasing worldwide; however, most existing data on AF epidemiology are from Western regions. According to our analyses, the estimated absolute prevalence of AF in the Asia–Pacific region in 2023 was approximately 80 million, which is much higher than has been calculated for other global regions.
Circulation
SEPTEMBER 24, 2024
Circulation, Ahead of Print. The science of cardiac rehabilitation and the secondary prevention of cardiovascular disease has progressed substantially since the most recent American Heart Association and American Association of Cardiovascular and Pulmonary Rehabilitation update on the core components of cardiac rehabilitation and secondary prevention programs was published in 2007.
Stroke Journal
SEPTEMBER 24, 2024
Stroke, Volume 55, Issue 10 , Page 2567-2572, October 1, 2024. In the 2024 David G. Sherman Lecture, Steven J. Warach, illustrating with examples from his research, walks through the history of magnetic resonance imaging in acute stroke from the 1990s and early 2000s with the introduction, validation, and application of diffusion-weighted imaging, penumbral imaging (the diffusion-perfusion mismatch), and other imaging markers of the acute stroke pathology into routine clinical practice and strok
HCPLive
SEPTEMBER 24, 2024
The ESS device, leveraging artificial intelligence, may allow for enhanced decision making among nurse practitioners as well as physician assistants evaluating patients for skin cancer.
Becker's Hospital Review - Cardiology
SEPTEMBER 24, 2024
Four leaders from cardiology hospitals that were ranked among the best by U.S. News & World Report shared with Becker's what they believe is the industry's biggest opportunity for growth.
HCPLive
SEPTEMBER 24, 2024
Laurence Sperling, MD, discusses his presentation from the 2024 Family Heart Global Summit examining public health efforts for prevention of cardiovascular disease.
American College of Cardiology
SEPTEMBER 24, 2024
The following are key points to remember from the 2024 American Heart Association/American College of Cardiology (AHA/ACC)/multisociety guideline for perioperative cardiovascular (CV) management for noncardiac surgery.
Becker's Hospital Review - Cardiology
SEPTEMBER 24, 2024
Cleveland Clinic, Chesterfield, Mo.-based Mercy and Bentonville, Ark.-based nonprofit organizations the Alice L. Walton Foundation and the Heartland Whole Health Institute have partnered to invest $700 million over 30 years to improve care access in Arkansas.
HCPLive
SEPTEMBER 24, 2024
These data from the DISCREET study highlight the impact of apremilast on men and women with genital psoriasis.
Society of Thoracic Surgeons - Adult Cardiac
SEPTEMBER 24, 2024
Video Latin Heart Rounds: Tetralogy of Fallot Update kchalko Tue, 09/24/2024 - 16:04 This video is based on the Latin Heart Rounds webinar series on the current management of patients with tetralogy of Fallot, including neonates and on the current short and long term outcomes for this congenital heart disease. The entire webinar is available here. The content is presented in Spanish.
HCPLive
SEPTEMBER 24, 2024
The announcement follows July’s approval of the nasal spray, also known as neffy, for patients with Type 1 allergic reactions such as anaphylaxis.
Becker's Hospital Review - Cardiology
SEPTEMBER 24, 2024
Cincinnati Children's and Indianapolis-based Peyton Manning Children's Hospital at Ascension St. Vincent have partnered to improve pediatric cardiology care.
HCPLive
SEPTEMBER 24, 2024
Nihar Desai, MD, discusses the results of the PROMPT-Lipid trial while on-site at the 2024 Family Heart Global Summit.
Becker's Hospital Review - Cardiology
SEPTEMBER 24, 2024
Cambridge, Mass.-based Harvard University topped U.S. News & World Report 's 2024 list of the best universities for cardiac and cardiovascular systems in the U.S.
HCPLive
SEPTEMBER 24, 2024
HCPLive spoke to Johnson on how strategies for addressing patient misconceptions about cholesterol management.
JAMA Cardiology
SEPTEMBER 24, 2024
This cohort study evaluates the association of late gadolinium enhancement with sudden cardiac death or relevant associated events among patients younger than 21 years with hypertrophic cardiomyopathy.
HCPLive
SEPTEMBER 24, 2024
Concomitantly, other treatment modalities such as physical and occupational therapy, anticonvulsants, topical analgesics, and psychosocial treatment have increased.
American College of Cardiology
SEPTEMBER 24, 2024
Is thrombectomy superior to medical management alone in patients with anterior circulation large vessel occlusion (LVO) and large infarct on noncontrast head computed tomography (NCHCT) only who can be treated within 24 hours of last known normal?
HCPLive
SEPTEMBER 24, 2024
The analysis of LDL-C Management Trends observed disparities in LDL-C goal attainment by race, gender, and age.
Medical Xpress - Cardiology
SEPTEMBER 24, 2024
There is a J-shaped association between systemic immune-inflammation index (SII) levels and all-cause mortality in patients with chronic kidney disease (CKD), according to a study published online Sept. 10 in Immunity, Inflammation and Disease.
HCPLive
SEPTEMBER 24, 2024
A handheld tool improved skin cancer detection in primary care, increasing diagnostic sensitivity to 96.3% compared to 83.9% without the device.
Becker's Hospital Review - Cardiology
SEPTEMBER 24, 2024
A new program at the University of California Irvine is designed to train the next generation of healthcare leaders to address issues of access and equity across cardiac care.
HCPLive
SEPTEMBER 24, 2024
The therapy demonstrated superior efficacy in combination with SOC over SOC alone.
DAIC
SEPTEMBER 24, 2024
tim.hodson Tue, 09/24/2024 - 15:46 Sept. 24, 2024 — Thrombolytic Science, LLC (TSI) has announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme. A U.S.-based clinical trial will further confirm the safety and tolerability of TSI's novel mutant prourokinase (mproUK) in healthy volunteers.
HCPLive
SEPTEMBER 24, 2024
Adding semaglutide to standard hidradenitis suppurative therapies achieved improvements in quality of life and fewer disease-related flares.
American College of Cardiology
SEPTEMBER 24, 2024
What are the clinical features and prognosis of patients with high-gradient (HG) aortic stenosis (AS) with a calculated aortic valve area (AVA) of >1.0 cm2?
HCPLive
SEPTEMBER 24, 2024
At the Family Heart Summit, Nihar Desai, MD, discussed using EMR alerts to improve lipid therapy for high-risk ASCVD, as shown in the PROMPT-Lipid trial.
JAMA Cardiology
SEPTEMBER 24, 2024
This cohort study investigates associations between a composite score for guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction at the time of discharge and clinical outcomes and costs.
HCPLive
SEPTEMBER 24, 2024
Magnetic resonance elastography and transient elastography did not accurately predict high-grade fibrosis on liver biopsy in children with MASLD.
HeartRhythm
SEPTEMBER 24, 2024
Current data on outcomes of an initial strategy of catheter ablation versus advanced therapy in patients with severe HF and ES are limited.
Expert insights. Personalized for you.
130 
Let's personalize your content